Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19

Yingning Li1, Zhen Wang1, Naqi Lian1

  • 1Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin Research Institute of Anesthesiology, Tianjin, China.

Frontiers in Medicine
|November 8, 2021
PubMed

Insights

Hydrogen gas shows promise for treating COVID-19 by reducing harmful inflammation. This therapy, explored in China, offers a potential new approach for managing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Area of Science:

  • Biomedical Science
  • Respiratory Medicine
  • Inflammation Research

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, lacks specific effective treatments.
  • The disease involves an excessive inflammatory response, often termed an 'inflammatory storm', crucial to its progression.
  • Hydrogen has demonstrated therapeutic potential across various diseases by modulating inflammatory processes.

Purpose of the Study:

  • To elucidate the pathophysiological mechanisms of COVID-19.
  • To review the therapeutic effects and mechanisms of hydrogen in treating critical COVID-19.
  • To analyze the feasibility and potential targets for hydrogen therapy in COVID-19 management.

Main Methods:

  • Review of existing literature on COVID-19 pathophysiology.
  • Analysis of studies investigating hydrogen's anti-inflammatory properties.
  • Examination of clinical research and treatment plans involving hydrogen-oxygen gas inhalation for COVID-19.

Main Results:

  • Hydrogen therapy, including inhalation of hydrogen-oxygen gas mixtures, is being explored as a treatment for COVID-19.
  • Emerging evidence suggests hydrogen can inhibit excessive inflammatory cells and factors implicated in severe COVID-19.
  • Hydrogen therapy has been incorporated into new COVID-19 treatment plans in China.

Conclusions:

  • Hydrogen exhibits potential as an effective therapeutic agent for COVID-19 due to its anti-inflammatory actions.
  • Further research into the mechanisms and therapeutic targets of hydrogen is warranted for optimizing COVID-19 treatment.
  • Hydrogen therapy represents a promising complementary or alternative strategy for managing COVID-19, particularly its severe inflammatory manifestations.

Related Concept Videos

Hydrogen Bonds00:26

Hydrogen Bonds

Hydrogen bonds are weak attractions between atoms that have formed other chemical bonds. One of these atoms is electronegative, like oxygen, and has a partial negative charge. The other is a hydrogen atom that has bonded with another electronegative atom and has a partial positive charge.
Hydrogen Bonds Control the World!
Because hydrogen has very weak electronegativity when it binds with a strongly electronegative atom, such as oxygen or nitrogen, electrons in the bond are unequally shared....
127.5K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
377
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation02:17

Reduction of Alkenes: Asymmetric Catalytic Hydrogenation

Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.5K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
622
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
497
Reduction of Alkenes: Catalytic Hydrogenation02:13

Reduction of Alkenes: Catalytic Hydrogenation

Alkenes undergo reduction by the addition of molecular hydrogen to give alkanes. Because the process generally occurs in the presence of a transition-metal catalyst, the reaction is called catalytic hydrogenation.
Metals like palladium, platinum, and nickel are commonly used in their solid forms — fine powder on an inert surface. As these catalysts remain insoluble in the reaction mixture, they are referred to as heterogeneous catalysts.
The hydrogenation process takes place on the...
12.7K